TME-Activated Nanofactory Orchestrate NIR-II Fluorescence/Photoacoustic Imaging-Guided Synergistic Chemodynamic/Photothermal Antitumor Therapy.
Triple-negative breast cancer (TNBC) is a highly aggressive and lethal malignancy with poor response to conventional therapeutic regimens. Thus, there is an urgent need to develop precision theranostic nanoplatforms that integrate accurate imaging guidance with synergistic therapeutic modalities. Herein, a novel respon...